Clinical depression follow-up: Difference between revisions
No edit summary |
Rim Halaby (talk | contribs) |
||
| Line 9: | Line 9: | ||
==Follow-up== | ==Follow-up== | ||
The [http://www.va.gov/ | The [http://www.va.gov/VA]/[http://www.defense.gov/ DoD] [[clinical practice guideline]]s for management of major depressive disorder recommends the following regarding the follow up of patients:<ref name="VA">VA/DoD [http://www.healthquality.va.gov/guidelines/MH/mdd/ clinical practice guideline for the management of major depressive disorder (MDD)]. Guideline summary. Washington (DC): Department of Veterans Affairs (U.S.); 2009</ref> | ||
* The follow-up period from the time of initial diagnosis is four to six weeks. | * The follow-up period from the time of initial diagnosis is four to six weeks. | ||
* At time of follow-up, a repeat PHQ-9 and an evaluation of the risk for suicide should be completed in order to assess treatment response. | * At time of follow-up, a repeat PHQ-9 and an evaluation of the risk for suicide should be completed in order to assess treatment response. | ||
Revision as of 12:22, 14 October 2014
|
Clinical Depression Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Follow-up |
|
Case Studies |
|
Clinical depression follow-up On the Web |
|
American Roentgen Ray Society Images of Clinical depression follow-up |
|
Risk calculators and risk factors for Clinical depression follow-up |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Patients with clinical depression should be followed up four to six weeks following the initiation of the treatment to assess for improvement of symptoms and treatment adherence.[1][2] This is based on clinical practice guidelines by the Veteran Affairs/Department of Defense (VA/DoD) and American Psychiatric Association.
Follow-up
The [2]/DoD clinical practice guidelines for management of major depressive disorder recommends the following regarding the follow up of patients:[1]
- The follow-up period from the time of initial diagnosis is four to six weeks.
- At time of follow-up, a repeat PHQ-9 and an evaluation of the risk for suicide should be completed in order to assess treatment response.
- How well treatment was tolerated, adherence to treatment, other influential medical problems, and psychosocial barriers to therapy should also be addressed at the time of follow-up.
References
- ↑ 1.0 1.1 VA/DoD clinical practice guideline for the management of major depressive disorder (MDD). Guideline summary. Washington (DC): Department of Veterans Affairs (U.S.); 2009
- ↑ American Psychiatric Association (APA). Practice guideline for the treatment of patients with major depressive disorder. 3rd ed. Arlington (VA): American Psychiatric Association (APA); 2010 Oct. 152 p. [1170 references] doi:10.1176/appi.books.9780890423387.654001